Camlin Fine Sciences

169.28
-4.28
(-2.47%)
ann
There are new updates from the company4 hours ago
Viewcross
right
Market Cap
3,181.13 Cr
EPS
-5.58
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
180.86
52 Week Low
78.11
PB Ratio
3.74
Debt to Equity
0.94
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+50.00 %
+50.00 %
Hold+50.00 %
+50.00 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,823.05 1,43,593.32 71.63 12,522.60 5.69 1,747 9.04 57.81
2,945.65 87,316.38 77.33 13,221.50 -11.53 1,336 6.99 56.46
3,985.20 43,777.42 96.01 4,387.70 -25.09 435 57.50 63.09
2,037.50 27,790.08 41.36 7,757.90 -3.26 811 -51.46 50.21
432.85 21,368.99 43.86 4,227.40 0.66 411 29.69 48.56
4,206.45 20,852.60 78.83 2,120.90 0.37 271 7.18 59.81
4,430.10 19,175.97 32.22 13,843.30 - 563 -26.05 43.43
5,809.45 17,104.04 42.46 4,783.90 -13.69 324 62.41 51.94
1,605.55 16,644.04 42.69 1,938.80 -8.77 323 21.85 50.85
397.90 14,424.64 40.56 6,380.70 -3.61 417 -62.90 46.14
Growth Rate
Revenue Growth
-3.48 %
Net Income Growth
-363.57 %
Cash Flow Change
173.05 %
ROE
-353.42 %
ROCE
-129.11 %
EBITDA Margin (Avg.)
-56.12 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
152
123
115
119
132
142
111
143
153
139
150
210
241
185
211
242
273
261
223
275
296
306
258
299
329
341
312
386
411
385
486
398
429
426
408
388
408
398
436
435
Expenses
120
94
99
106
104
122
94
132
158
150
142
202
221
168
184
226
251
225
192
244
259
255
223
251
276
285
289
326
365
337
428
338
393
381
381
363
465
378
531
387
EBITDA
32
29
16
14
28
21
17
11
-6
-11
8
8
19
18
27
16
21
36
31
30
37
52
35
48
53
56
23
61
46
48
58
60
36
45
27
25
-57
20
-95
48
Operating Profit %
17 %
23 %
13 %
11 %
21 %
11 %
16 %
1 %
-5 %
-8 %
3 %
3 %
5 %
8 %
9 %
6 %
6 %
14 %
14 %
11 %
12 %
17 %
13 %
16 %
15 %
14 %
7 %
14 %
6 %
12 %
11 %
13 %
8 %
9 %
6 %
6 %
-16 %
5 %
-25 %
11 %
Depreciation
5
4
4
4
5
5
6
6
6
5
6
6
10
7
8
7
7
8
8
8
9
10
10
13
12
13
13
13
16
14
14
16
18
19
19
21
20
20
21
15
Interest
7
6
6
6
7
7
6
9
5
6
8
10
4
9
10
11
7
6
14
8
15
11
8
7
12
10
9
7
10
19
19
12
10
10
20
14
16
23
26
34
Profit Before Tax
20
20
8
5
17
9
6
-3
-17
-22
-6
-8
5
2
10
-2
7
23
9
14
13
32
17
28
29
33
1
41
20
15
26
32
8
16
-12
-10
-94
-24
-142
-0
Tax
-3
6
3
2
3
6
5
0
-12
-10
-3
-3
10
6
8
-1
0
6
1
10
11
11
8
8
13
9
5
14
7
11
16
9
5
4
9
5
-12
11
-26
7
Net Profit
23
14
5
3
14
3
1
-4
-5
-11
-3
-5
-4
-4
2
-1
6
16
8
4
2
21
10
19
16
24
-4
27
13
4
10
23
4
12
-21
-14
-82
-35
-116
-8
EPS in ₹
0.47
1.45
0.53
0.27
1.48
0.12
0.07
-0.33
-0.85
-1.16
-0.40
-1.36
-0.66
-0.49
0.11
-0.17
0.60
1.28
0.57
0.43
0.22
1.27
0.49
1.26
1.16
1.75
-0.43
2.25
1.16
0.37
0.83
1.53
0.59
0.96
-1.17
-0.71
-4.64
-2.03
-5.98
-0.24

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
430
483
673
1,017
1,087
1,234
1,482
1,800
2,060
1,952
Fixed Assets
106
140
201
278
272
306
584
601
858
816
Current Assets
299
300
419
666
673
675
795
894
1,088
1,001
Capital Work in Progress
3
25
8
14
59
179
24
215
43
46
Investments
0
0
19
115
11
7
7
7
8
8
Other Assets
320
317
445
609
745
742
867
977
1,152
1,082
Total Liabilities
430
483
673
1,017
1,087
1,234
1,482
1,800
2,060
1,952
Current Liabilities
262
280
386
471
460
548
478
595
793
732
Non Current Liabilities
33
27
57
112
196
226
291
440
443
363
Total Equity
135
176
230
433
430
460
713
765
824
857
Reserve & Surplus
125
167
202
359
355
388
582
729
800
845
Share Capital
10
10
10
12
12
12
13
16
16
17

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
5
-1
13
18
15
-1
23
32
-14
-14
Investing Activities
-26
-66
-70
-149
-2
-90
-133
-249
-125
-67
Operating Activities
46
72
-9
-15
-9
86
117
145
51
139
Financing Activities
-16
-7
91
182
26
3
39
136
60
-86

Share Holding

% Holding
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Jan 2025
Promoter
41.14 %
41.14 %
40.95 %
40.96 %
40.93 %
35.06 %
22.37 %
22.39 %
22.49 %
22.66 %
22.66 %
22.66 %
22.70 %
22.85 %
22.85 %
22.85 %
22.84 %
21.74 %
21.73 %
21.71 %
21.71 %
21.71 %
17.65 %
17.64 %
17.64 %
17.64 %
17.64 %
16.52 %
48.03 %
48.03 %
48.03 %
48.02 %
48.02 %
48.02 %
49.10 %
FIIs
8.75 %
7.00 %
7.56 %
7.76 %
2.54 %
2.29 %
4.73 %
4.26 %
1.30 %
1.37 %
1.25 %
1.12 %
0.93 %
0.89 %
1.22 %
1.16 %
1.75 %
1.71 %
4.71 %
5.28 %
5.01 %
4.81 %
10.50 %
10.74 %
11.32 %
10.94 %
10.18 %
0.00 %
0.00 %
0.00 %
1.69 %
1.01 %
0.81 %
0.76 %
0.82 %
DIIs
2.81 %
3.42 %
4.69 %
5.02 %
6.72 %
16.82 %
18.49 %
19.25 %
19.97 %
19.04 %
19.02 %
19.13 %
21.23 %
21.41 %
21.06 %
18.97 %
18.99 %
20.34 %
20.21 %
19.71 %
19.03 %
17.88 %
14.47 %
14.20 %
13.53 %
12.53 %
12.33 %
9.31 %
2.74 %
2.75 %
4.54 %
4.89 %
4.24 %
3.39 %
4.09 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.40 %
0.40 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.03 %
0.03 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.94 %
28.56 %
28.28 %
27.57 %
28.29 %
26.07 %
30.94 %
31.32 %
33.29 %
34.51 %
34.76 %
35.09 %
36.61 %
34.30 %
34.45 %
35.65 %
35.89 %
33.57 %
31.21 %
35.11 %
35.68 %
36.69 %
30.32 %
30.77 %
30.32 %
31.31 %
31.30 %
30.41 %
33.23 %
34.18 %
32.75 %
33.89 %
34.52 %
35.13 %
33.14 %
Others
17.36 %
19.88 %
18.52 %
18.69 %
21.53 %
19.36 %
23.07 %
22.78 %
22.95 %
22.42 %
22.30 %
22.00 %
18.53 %
20.56 %
20.42 %
21.37 %
20.53 %
22.65 %
22.14 %
18.18 %
18.56 %
18.91 %
27.05 %
26.65 %
27.19 %
27.57 %
28.51 %
43.72 %
16.00 %
15.04 %
12.99 %
12.19 %
12.41 %
12.70 %
12.85 %
No of Share Holders
30,639
28,337
29,209
29,101
29,767
26,478
31,972
34,096
36,498
36,717
35,885
35,285
33,154
33,849
41,630
43,139
39,500
40,599
38,712
41,543
51,038
56,394
55,277
57,835
57,904
54,197
52,921
52,278
57,098
62,098
58,165
62,687
67,750
61,893
60,554

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
4 hours ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
1 day ago
Update On Analyst / Institutional Investor Meeting
7 days ago
Update On Joint Press Release
Mar 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mar 12, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Mar 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mar 12, 2025
Update On Press Release
Feb 25, 2025
Update On Press Release
Feb 25, 2025
Disclosure Pursuant To Clause 5 Of Para B Of Part A Of Schedule III Of SEBI LODR Regulations 2015
Feb 24, 2025
Announcement under Regulation 30 (LODR)-Acquisition
Feb 24, 2025
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 14, 2025
Integrated Filing (Financial)
Feb 14, 2025
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 14, 2025
Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024
Feb 14, 2025
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024
Feb 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 08, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Feb 06, 2025
Board Meeting Intimation for Intimation About The Board Meeting Of Camlin Fine Sciences Limited (The Company) To Be Held On February 14 2025
Feb 06, 2025
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Asst./D
Feb 05, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Feb 05, 2025
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Update On Intimation Made Regarding Receipt Of Closure Direction Fo
Feb 01, 2025
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Commiss
Feb 01, 2025
Announcement under Regulation 30 (LODR)-Allotment
Jan 31, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited
Jan 31, 2025
Clarification
Jan 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 20, 2025
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
Jan 18, 2025
Intimation Regarding Receipt Of Closure Direction For Our Unit Situated At SEZ Dahej Bharuch.
Jan 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 15, 2025
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Commiss
Jan 14, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited (The Company) Held On January 9 2025
Jan 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 06, 2025
Intimation Regarding Change In The Name Of Registrar And Share Transfer Agent (RTA) Of Camlin Fine Sciences Limited (The Company).
Jan 03, 2025
Rights Issue - Record Date Is Wednesday January 8 2025
Jan 02, 2025
Announcement under Regulation 30 (LODR)-Raising of Funds
Jan 02, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited (The Company) Held On January 2 2025.
Jan 02, 2025
Board Meeting Intimation for Intimation Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors To Be Held On Thursday January 2 2025.
Dec 30, 2024
Announcement under Regulation 30 (LODR)-Change in Management
Dec 16, 2024
Update For An Announcement Made Under Regulation 30 (LODR)-Change In Management Dated November 11, 2024
Dec 13, 2024
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Dec 11, 2024
Announcement under Regulation 30 (LODR)-Allotment
Dec 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 04, 2024
Announcement under Regulation 30 (LODR)-Issue of Securities
Nov 22, 2024
Board Meeting Outcome for The Revision Of The Quantum Of The Proposed Rights Issue To An Amount Not Exceeding Rs. 225 Crores And Proposal For Fund Raising By Way Of Issuance Of Non-Convertible Debentures Aggregating For An Amount Of Rs. 100 Crores On A Private Placement Basis.
Nov 22, 2024
Board Meeting Intimation for The Revision Of The Quantum Of The Proposed Rights Issue To An Amount Not Exceeding Rs. 225 Crores; And Issue Of Any Debt Securities Of The Company.
Nov 18, 2024

Technical Indicators

RSI(14)
Neutral
62.90
ATR(14)
Volatile
8.65
STOCH(9,6)
Neutral
72.83
STOCH RSI(14)
Neutral
43.99
MACD(12,26)
Bearish
-0.01
ADX(14)
Strong Trend
40.64
UO(9)
Bearish
55.95
ROC(12)
Uptrend But Slowing Down
2.97
WillR(14)
Neutral
-22.36